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Abstract
Proteostasis (Balch et al. (2008) Science 319: 916) refers to the biology that maintains the proteome
in health and disease. Proteostasis is challenged by the most common mutation in cystic fibrosis,
ΔF508, a chloride channel (the cystic fibrosis transmembrane conductance regulator (CFTR)) that
exhibits a temperature-sensitive phenotype for coupling to the coatomer complex II (COPII) transport
machine for exit from the endoplasmic reticulum (ER). Whether rescue of export of ΔF508-CFTR
at reduced temperature simply reflects energetic stabilization of the chemical fold defined by its
primary sequence, or requires a unique proteostasis environment is unknown. We now show that
reduced temperature (30°C) export of ΔF508 does not occur in some cell types despite efficient export
of wild-type CFTR. We find ΔF508 export requires a local biological folding environment that is
sensitive to heat/stress inducible factors found in some cell types suggesting that the energetic
stabilization by reduced temperature is necessary, but not sufficient for export of ΔF508. Thus, the
cell may require a proteostasis environment that is in part distinct from the wild-type pathway to
restore ΔF508 coupling to COPII. These results are discussed in the context of the energetics of the
protein fold and the potential application of small molecules to achieve a proteostasis environment
favoring export of a functional form of ΔF508.
Cystic fibrosis (CF) is one of the most common lethal inherited disorders among Caucasians
with an incidence of one in 2500 live births. The disease is caused by mutations within the
gene encoding a cell surface cAMP-dependent chloride channel, the cystic fibrosis
transmembrane conductance regulator (CFTR) (1). CFTR is a multi-membrane spanning
protein that contains functionally important cytoplasmic domains including the N-and C-
termini, and the nucleotide-binding domain 1 (NBD1), regulatory (R) domain and NBD2 that
together regulate channel function and trafficking (2,3). Folding of newly synthesized full-
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length CFTR in vivo requires ~5–10 min, emphasizing the importance of chaperone mediated
folding pathways in coordinating both intra- and inter-domain interactions (4–13).
The most common mutation in CFTR, present in 90% of CF patients, is the deletion of a
phenylalanine 508 (ΔF508) in the cytosolic NBD1, that triggers misfolding and degradation
leading to the loss-of-function disease. A number of studies from analysis of the folding of
recombinant NBD1 in vitro have demonstrated that the Phe 508 deletion affects the folding
kinetics of NBD1, but not the thermodynamic stability of the folded mutant protein when
compared to wild-type NBD1 (14–16). Stabilizing the fold with second site suppressor
mutations can eliminate instability (17–19). These cis-acting suppressors implicate kinetic
instability of the misfolded NBD1 as an early event in the biological folding pathway of CFTR.
The contribution of protein homeostasis or proteostasis programs, that is, the biology that
maintains and protects the cellular proteome (20), and that directs CFTR folding (13) remains
a major challenge for the field to understand. Patients homozygous for the Phe508 deletion
have severe disease. While retaining some channel activity, the ΔF508 CFTR folding defect
largely prevents the protein from exiting the endoplasmic reticulum (ER) (2,21,22). As a result,
ΔF508 CFTR is principally degraded by ER-associated degradation (ERAD) pathways (23,
24). The absence of CFTR on the plasma membrane in a variety of tissues (e.g., lung, pancreas,
intestine) results in an imbalance of Na+, Cl−, and HCO3 − leading to a loss of hydration of the
extracellular surface. In the case of lung tissue, defective muciliary clearance leads to lung
disease, the major cause of premature death (25–29). While a number of genetic modifiers
affect the clinical presentation of CF, they are largely involved in downstream events affecting
the severity of disease independent of the initial folding/trafficking pathways (30–32). Thus,
the potential importance of factors that affect ΔF508 folding and trafficking, and/or the cellular/
tissue response to the absence of channel activity leading to the observed clinical phenotype
remain to be elucidated (13,33–36).
Export from the ER is dependent on the kinetic and thermodynamic stability of the nascent
polypeptide (20,37–39). Here, ER-associated protein folding (ERAF) and degradation (ERAD)
pathways define metabolic pathway(s) that utilize a variety of general and specialized
chaperones comprising the local chaperone environment that are present in either the lumen
of the ER or at the cytosolic face to facilitate the folding and stability of the nascent polypeptide
(20). Exit from the ER is orchestrated by the COPII vesicle budding machinery that includes
the Sar1 GTPase and the coat components Sec23–24 and Sec13–31 (40,41). Sec23–24
functions as a ‘selector’ that recognizes cargo for export whereas Sec13–31 functions as a self-
assembling ‘collector’ that concentrates cargo bound to the Sec23–24 adaptor complex to
generate transport vesicles that bud from the ER (42). Work by our group and others has shown
that selection for export by the Sec24 COPII component involves recognition of a conserved
di-acidic exit code found in the cytosolic tail of a number of transmembrane proteins and in
the NBD1 domain of CFTR (43–45).
Export of ΔF508 CFTR is temperature-sensitive (43,46). At reduced temperature (27–32°C),
ΔF508 CFTR can exit the ER, acquire the Golgi-specific N-linked glycan modifications and
can function as a channel on the cell surface. Curiously, the efficiency of export at reduced
temperature, like export at 37°, appears to be variable among different cell types and is the
matter of some debate ((47) and references therein), raising the possibility that a specific
chaperome environment (13) and/or other factors mediate export at reduced temperature.
Moreover, the restoration of channel conductance following export at reduced temperature
appears to be only partial and its half-life on the cell surface is markedly reduced following
transfer of cells back to 37°C where ΔF508 CFTR can be rapidly targeted to the lysosome for
degradation, likely through ubiquitin-dependent mechanisms (6,7,21,48–50). Thus, reduced
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temperature, while supportive of export of ΔF508, does not appear to convey a normal fold,
trafficking or processing pattern that is fully functional at physiological temperatures.
Previous studies have implicated a role for both the Hsc- Hsp70 and Hsp90 families of
chaperones as well as other components in folding, degradation and export of wild-type and
ΔF508 CFTR from the ER at physiological temperature (13,24,51–66). In contrast, the
mechanism(s) by which reduced temperature functions to permit ER export of ΔF508 CFTR
is largely unknown. One view is that reduced temperature simply conveys kinetic and/or
thermodynamic stability to the ΔF508 CFTR chemical folding pathway, a pathway defined by
the mutated polypeptide chain sequence (38,67), and that this pathway utilizes the same
components as wild-type CFR. This interpretation is consistent with biochemical studies in
vitro where the isolated ΔF508 NBD1 domain in solution is kinetically destabilized relative to
the wild-type fold (16,17,68). Furthermore, a defect in the chemical fold is supported by the
observation that high concentrations of organic solvents such as glycerol that purportedly
function only as ‘chemical chaperones’ by stabilizing the protein fold, promote ΔF508 CFTR
export in vivo at physiological temperatures (15,69–72).
On the other hand, a second view is that the variability in export between cell types at reduced
temperature involves a biological component(s) to promote the reduced temperature fold.
Whether these components are the same or different from those required to fold wild-type
CFTR at physiological temperature is unknown. Thus, an alternative, but not mutually
exclusive interpretation, is that a different chaperone activity(s) or balance of activities
facilitates reduced temperature folding of ΔF508 CFTR when compared to the requirements
for wild-type CFTR. If an energetic transition reflecting the change in chemical stability
conferred by reduced temperature is the sole mechanism underlying the temperature-dependent
export of ΔF508 CFTR from the ER, a specific prediction is that export of ΔF508 CFTR should
largely reflect what is seen for wild-type CFTR in the same cell type, albeit with reduced
kinetics. In contrast, a chaperone-dependent, perhaps, partially distinct folding pathway model
would predict that the temperature-dependent export of ΔF508 CFTR is cell-type dependent
and does not necessarily correlate with the ability of the cell to export wild-type CFTR,
reflecting differences in the local cellular pool(s) of chaperones and their regulators that are
available at a particular temperature for export (13,33). This issue has not been explored in any
systematic fashion.
To investigate the role of the cellular folding machinery on ΔF508 CFTR export at reduced
temperature, we have systematically examined the trafficking of CFTR in two cell lines, human
embryonic kidney (HEK) 293 and baby hamster kidney (BHK), each stably expressing either
wild-type or ΔF508 CFTR. While both BHK and HEK293 cell lines expressing wild-type
CFTR efficiently transport the protein to the cell surface at physiological and reduced
temperature, those expressing ΔF508 CFTR display strikingly different phenotypes. In
HEK293 cells expressing ΔF508 CFTR (referred to as HEK-ΔF), ΔF508 CFTR efficiently
exits the ER at reduced temperature. In contrast, a BHK strain stably expressing ΔF508 CFTR
(BHK-ΔF) exported ΔF508 CFTR very poorly at reduced temperature. Mild heat stress (40°
C for 3 h) or acute heat shock (42°C for 30 min) markedly enhanced stability for export of
ΔF508 CFTR from the ER in HEK-ΔF cells. However, similar conditions had no effect on
export of ΔF508 in the BHK-ΔF cell line. Thus, export at reduced temperature appears to be
dependent on folding factors that are compatible with the energetics of ΔF508 chain that are
available in the HEK293 cells, but not our BHK cell line strain. Such factors may contribute
to the variability in cell surface expression of ΔF508 CFTR observed in different cell lines at
physiological temperatures and reduced temperatures, and have an important impact on our
thinking about mechanisms of rescue of ΔF508 folding intermediates in clinical disease.
Wang et al. Page 3














Transport of wild-type CFTR in HEK293 and BHK cells
We first examined the transport of wild-type CFTR in baby hamster kidney (BHK) and human
embryonic kidney (HEK) 293 stable cell lines using a pulse-chase protocol at 37°C. CFTR
contains two high mannose N-linked oligosaccharides that are acquired during co-translational
insertion into the ER membrane bilayer (Fig. 1, band B) that are processed to the mature form
(Fig. 1, band C) containing complex sugars during transport through the Golgi to the cell surface
(73). As shown in Fig. 1A (top panel), HEK293 cells export wild-type CFTR slightly more
efficiently (average value of initial total labeled CFTR found in band C is ~60% at 2 h) when
compared to BHK cells (Fig. 1A, middle panel) (average value of initial total labeled CFTR
found in band C is ~40% at 2 h), with a proportionately larger pool of the pulse-labeled wild-
type CFTR subject to degradation in BHK cells. Despite the apparent slower kinetics of
transport of the pulse-labeled pool observed in BHK cells (Fig. 1A, compare 1 h time-point in
HEK293 (upper panel) vs. BHK (middle panel)), based on the steady state distribution CFTR
at 37°C using immunoblotting of cell lysates, wild type CFTR largely accumulates in the
mature cell surface form (band C) in both cell types. Here, with the core-glycosylated ER form
of CFTR (band B) accounts for less than 5–10% of the total pool (an approximate relative ratio
of 10:1 band C to band B, respectively, using quantitative immunoblotting of gels exposed in
the linear range (see Materials and Methods)) (Fig. 1B). In contrast, and consistent with its
inability to exit the ER at 37°C, at steady-state ΔF508 is principally if not entirely restricted
to the band B form at 37°C in both BHK and HEK293 cells reflecting either ERAD and/or
rapid turnover at the cell surface of ΔF508 that escapes the ER (Fig. 1B). Thus, although the
kinetics of export and stability is less efficient in the BHK cell line as shown by the pulse-chase
and the ratio of band C over band B (C/B ratio), a measure of efficiency of export of the pulse-
chased CFTR from the ER (Fig. 1A, lower panel), both BHK and HEK293 contain the
necessary folding machinery to export and maintain wild-type CFTR at the cell surface at
physiological temperature. These results are similar to those observed for transport of vesicular
stomatitis viral glycoprotein (VSV-G), a type 1 transmembrane protein, that is mobilized
rapidly to the cell surface in both cell types at 37°C (data not shown), suggesting that the
proteostasis machinery in both cell types is capable of folding and trafficking highly divergent
wild-type proteins.
Wild-type CFTR is efficiently exported at both 37°C and 30°C in HEK293 and BHK cells
ΔF508 CFTR is a temperature-sensitive variant that is not efficiently exported from the ER at
37°C, but has been shown to exit the ER at reduced temperature (27°C to 32°C). To ensure
that reduced temperature does not have a special effect on the function of the folding and export
machinery directing wild-type CFTR trafficking, we first examined the effects of reduced
temperature on the kinetics of export of wild-type CFTR. HEK293 or BHK cells stably
expressing wild-type CFTR were pulsed at 37°C and chased at either 37° or 30°C (Fig. 2A).
The pulse at 37°C reflects the steady-state translation and folding properties of both wild-type
and ΔF508 under physiological conditions, the critical concern in disease. As expected, while
incubation of cells at reduced temperature resulted in efficient recovery of wild-type in band
C after 3 h in both cell types (Fig. 2A), we observed a modest delay in the decrease of band B
and a corresponding slower processing of band B to C when compared to the 37°C incubation
in both cells (Fig. 2A). Overall, these results are consistent with the conclusion that wild-type
CFTR folding and export does not benefit from incubation of cells at lower temperatures,
undoubtedly reflecting the higher energetic stability of its folding intermediates when
compared to the ΔF508 fold (15,16). Thus, both cell lines possess the machinery to readily
direct folding, export and processing of wild-type CFTR at 37° and 30°C.
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ΔF508 shows cell-type specific export at reduced temperature
To analyze the ability of BHK and HEK293 cells to support temperature-dependent export of
ΔF508 CFTR, cell lines stably expressing human ΔF508 CFTR (denoted as BHK-ΔF and HEK-
ΔF) were incubated at a range of temperatures for 21 h, and the steady state distribution of
CFTR between bands B and C was analyzed by quantitative immunoblotting (Fig. 2B, upper
panels). ΔF508 CFTR largely remained in the band B form at 37°C in either cell line based on
its distribution at steady state (Fig. 2B; inset, upper panel, lane d), although we frequently
observed a band of intermediate migration between band B and C (referred to as band I) at 37°
C and the restrictive temperature (Fig. 2B; inset, upper, lanes d and e) (13). Based upon the
intermediate migration of band I and its insensitivity to endoglycosidase H (endo H) (Fig. 2B,
inset, middle panel), an enzyme that cleaves ER-associated high mannose, but not mannose-
trimmed, N-acetylglucosamine (GlcNAc) modified Golgi-associated N-linked
oligosaccharides, band I is likely a partially glycosylated form that appears following transit
to early (cis/medial) Golgi compartments prior to further addition of complex sugars. The latter
case is supported by our observations that such Golgi processing intermediates are routinely
observed for glycoproteins such as VSV-G transiting the exocytic pathway and are delivered
efficiently to the cell surface following further processing to complex oligosaccharides
containing galactose and sialic acid (74) (see below).
In HEK-ΔF cells, and consistent with previous reports (46), as the incubation temperature
decreased from 37°C to 27°C, the level of total band B observed at steady-state decreased with
the concomitant appearance of band C (Fig. 2B; inset, upper panel, lanes a–d). While the
appearance of band C was evident between 32°C and 27°C, the highest level of band C occurred
at 30°C in HEK-ΔF cells, presumably reflecting a balance between the relative rates of
translation, ERAF, ERAD, export from the ER and its cell surface stability. Using the total
amount of ΔF508 CFTR exported from the ER reflected in bands I+C (which measures both
ER exported ΔF508 CFTR and its steady-state stability in post-ER compartments and the cell
surface), and the total amount in the ER reflected in band B (which measures the steady-state
contribution of rates of translation, ERAD, and ERAF we can generate a ‘trafficking index’ or
TI that is quantitatively defined as the ratio (I + C)/B that defines the overall trafficking
environment of CFTR at steady-state. This value differs from the C/B ratio observed during
pulse-chase that only reflects a small fraction (the pulsed material) of the total CFTR pool in
the cell. Thus, in immunoblots, the TI is a value that reflects the overall balance between export
of CFTR from the ER and its stability at the cell surface relative to the available band B pool
under the indicated incubation conditions. TI serves as a useful index for the relative efficiency
of all factors that contribute to the overall trafficking and stability of CFTR in the mature Golgi
processed form at steady-state in a given cell type.
At 37°C or 30°C, the TI for wild-type CFTR encompasses a value range of 10–20 in the
HEK293 and BHK cell lines (Fig. 1B, Fig 2A). At 37°C, the TI for ΔF508 in either cell line
under the present incubation conditions is 0.1 to 0.3, a value that is substantially lower than
wild-type CFTR. Transfer to 30°C for 21 h results in a ~10-fold increase of in the TI of ΔF508
(to ~3) in HEK 293 cells (Fig. 2B, open circles). Thus, it is apparent that the TI markedly
increases with decreasing temperature in HEK293 cells, suggesting an improvement in both
folding and export at reduced temperature relative to rates of translation, ERAD and/or cell
surface stability. Interestingly, in HEK-ΔF cells, increasing the temperature of incubation from
37°C to 40°C stabilized the total recovery of both bands B and I (Fig. 2B; inset, upper panels,
lane e) without changing the steady-state value of the TI (Fig. 2B, open circles). The increase
in band B suggests that additional factors, possibly generated in response to mild heat stress,
may favor the induction of heat shock factors (75) to stabilize the ER-associated but not
necessarily post- ER pools (see below).
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In contrast to the effects of changing the incubation temperature of HEK-ΔF cells on ΔF508
export and the TI, the BHK-ΔF cell line did not support the low-temperature-dependent export
of ΔF508 CFTR from the ER under the current incubation conditions, even though decreased
temperature stabilized the steady-state levels of band B when compared to that observed at 37°
C (Fig. 2B; inset, middle panel, lanes a–d). Consistent with these results, the TI largely
remained invariant at ~0.1 (Fig. 2B, open circles and closed squares). We also observed modest
stabilization of band B following incubation under mild heat-stress conditions (40° C), yet no
conversion to band I or C (Fig. 2B; inset, middle panel, lane e; closed squares). The effects
observed were similar when butyrate was added to the culture media to elevate the expression
of ΔF508 by 10-fold (Fig. 2B; inset, lower panel), a condition that also yields a TI of ~0.1 (Fig.
2B, triangles), indicating that the absence of rescue does not simply reflect the steady-state
pool of CFTR in the ER.
We conclude that both cell lines can stabilize CFTR from degradation in the ER at reduced
temperature- evident in the increase in band B. In contrast, HEK-ΔF cells, but not BHK-ΔF
cells, have a folding/export machinery that can facilitate an increased recovery of ΔF508 CFTR
at the cell surface that is reflected in the increased TI in HEK293-ΔF (~10-fold), but not in
BHK-ΔF in response to reduced temperature even though both cell types transport wild-type
CFTR within a 2-fold range at reduced temperature (Fig. 2A). Thus, while changes in the
chemical fold, that is, the amino acid sequence defining the mutant polypeptide chain, can be
stabilized energetically by transfer to reduced temperature, reduced temperature is not
sufficient for folding of ΔF508. The mutant appears to require cell-specific factors in addition
to those necessary for normal folding and trafficking of wild-type CFTR that are found
HEK293 but not our strain of BHK.
Reduced temperature kinetically stabilizes band B prior to export
To kinetically characterize the response of ΔF508 CFTR to reduced temperature, we examined
the steady-state distribution of ΔF508 CFTR between the ER glycoform (band B) and post-ER
glycoforms (I + C) in each cell line following shift of cells from 37° C to 30° C for increasing
time. While we detected a progressive increase in the intensity of band C̣ in HEK-ΔF cells
following a brief lag period (Fig. 3A,B; ~8-fold by 21 h), BHK-ΔF cells showed no increase
in band C over the same time period of incubation (Fig. 3A,B). In HEK-ΔF cells, ΔF508 CFTR
transiently appeared in the band I intermediate. In subsequent time-points, band I was reduced
and accompanied by appearance of band C (Fig. 3A, C). One interpretation is that band I
matures to band C as a consequence of sequential transfer through cis, medial and trans Golgi
compartments en route to the cell surface as we have previously demonstrated for VSV-G
(74), although we cannot rule out the possibility that band I reflects CFTR retained by the early
Golgi, or a misfolded form that is degraded as a consequence of recycling to the ER and delivery
to ERAD pathways (76, 77). In any case, the ~3–4 fold increase in the TI in HEK-ΔF cells
(Fig. 3E) demonstrates that these cells can export ΔF508 more efficiently than BHK-ΔF by
incubation at reduced temperatures for increasing time.
Interestingly, in both cell lines, we first observed significant increase in the levels of band B
following shift to 30° C (Fig. 3A, D) when compared to the steady-state level observed at 37°
C prior to temperature shift. Following the increase, which peaked at 3 h in HEK-ΔF and at 6
h in BHK-ΔF, the steady state level of band B started to decline, more so in HEK-ΔF cells than
in BHK-ΔF cells. In HEK-ΔF cells, these results raise the possibility that at reduced
temperature a cellular machinery may initially stabilize nascent ΔF508 CFTR (e.g., band B)
in the ER from ERAD relative to the rate of translation. This stabilized conformation could
subsequently engage the export machinery, reflected in the transit through the cis- medial (band
I) (74) and trans (band C) Golgi compartments (Fig. 3) preceding delivery to the cell surface.
In contrast, while BHK-ΔF cells were also able to increase the steady-state level of ΔF508 in
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the ER, the apparent absence of factor(s) that promotes folding for coupling of the reduced
temperature folded band B to the COPII export machinery results in its nearly quantitative
degradation. The fact that we observed stabilization of band B in both BHK-ΔF and HEK-ΔF
at 30°C, yet no export in BHK-ΔF (Fig. 3), demonstrates that a step in common between the
two cell types involves partitioning away from the degradation pathway at reduced
temperature. However, it is apparent that in BHK cells the chemical fold induced by
temperature shift itself is not sufficient to achieve a conformational change in ΔF508 necessary
to engage the COPII machinery. Thus, HEK293 cells contain additional factors to promote
folding for protein egress from the ER and stability at the cell surface at reduced temperature.
Heat-stress enhances the export of ΔF508 CFTR at reduced temperature
Numerous studies have focused on the role(s) of chaperones in the delivery of ΔF508 and wild-
type CFTR to both ERAD pathways and export (4,10,13,51,53–61,63,78). We noted that mild
heat-stress (21 h at 40°C) in HEK293 increased the steady-state level of band B of ΔF508
CFTR and the level of band I proportionally, but not that of band C, relative to that observed
at 37°C (Fig. 2B; inset, upper panels, compare lane d to e). The absence of band C at 40°C
suggests that either band I is recycled for ERAD in the ER, or is processed to band C, but is
very unstable at the cell surface at this elevated temperature and is rapidly degraded by targeting
to lysosome in a fashion that precludes detection at steady-state.
To determine if preincubation at 40°C could enhance the level of export of ΔF508 CFTR from
the ER following shift to reduced temperature, HEK-ΔF cells were incubated at 40°C overnight
(21 h), followed by incubation at 30° C for increasing time as described above. To facilitate
comparison, we normalized the steady state level of ΔF508 CFTR in its ER (band B) and post-
ER (band I+C) glycoforms to the level of ΔF508 CFTR in band B at time 0. While incubation
at 40° C increased significantly the band B pool in HEK-ΔF cells relative to the no pre-heat
control (Fig. 2B, inset, upper panels; Fig. 4A, t=0), following downshift of these cells to 30°
C for 3 h, we observed a additional increase of nascent band B relative to the no pre-heat
control. A similar result was observed for band C and both continued to increase until ~ 9 h
(Fig. 4A,B). Between 9–15 h we observed a decrease in both B and C, suggesting loss of the
heat inducible stabilization environment. (Fig. 4A, B and C), although typically band I+C began
to accumulate again after 15 h. This increase in I+C was correlated with an increase in export
efficiency with a TI index of ~2 at 9 h and ~3 at 21 h (Fig. 4A, C). We conclude that preheat
promotes the transient stabilization and export of ΔF508 CFTR during the subsequent
incubation at reduced temperature in a complex fashion likely reflecting multiple changes in
the folding, trafficking and stability environment.
Since BHK-ΔF cells do not support the reduced temperature-dependent export ΔF508 CFTR
(Fig. 2, Fig. 3), we examined if a similar approach of mild heat-stress for 21 h at 40°C would
rescue the defective export of ΔF508 CFTR in these cells following shift to 30° C. Relative to
the no preheat control, neither enhanced stabilization of band B nor appearance of band C was
observed (Fig. 4D–F).
To further examine the role of mild (40° C) heat-stress in HEK-ΔF, we performed pulse-chase
analysis at 30°C following mild treatment of cells for 21 h at 40° C (Fig. 5). Consistent with
the steady-state results, we observed a ~2 fold enhancement of the initial band B level in heat-
treated versus the no preheat control during the pulse period (Fig. 5A, t=0) prior to shift to 30°
C. However, following shift to 30°C we observed a rate of loss of band B that was similar in
both the no pre-heat controls and 40°C treated cells (Fig. 5B–C, open circles), suggesting that
the higher level band B observed during the brief pulse at 40°C may represent an increased
rate of translation or stabilization. Following temperature shift to 30°C we observed the
expected conversion of labeled ΔF508 CFTR to bands C (Fig. 5A; B–C, closed circles). The
relative export efficiency in heat-treated cells compared to control cells after the 4 h time-point
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was elevated as reflected in the increase in the ratio of C/B during the pulse-chase. Thus, the
increased steady-state level of band C in response to mild heat-stress (Fig. 4) appears to reflect
a shift toward a pathway in which newly synthesized CFTR favors ER export in HEK293.
A brief exposure to mild heat stress confers rescue
To determine the minimum time of mild heat treatment (40° C) required to enhance ΔF508
CFTR export, we examined the effect of increasing exposure of cells to 40° C prior to
incubation at 30° C or 37° C for 18 h (Fig. 6A). Increasing time of exposure to 40° C had a
very modest effect on ΔF508 processing upon subsequent incubation of cells at 37° C (Fig.
6A; 6B, upper and middle panels, closed triangles). In contrast, when cells were incubated at
30° C, the effects of mild heat stress on band B levels and processing to bands I + C were first
evident between 0.5 and 3 h pre-incubation at 40° C (Fig. 6A; 6B, upper and middle panels,
closed circles). This increase was blocked by the addition of the transcription inhibitor
actinomycin D (Fig. 6C), suggesting that inducible factors are likely participating in the high
temperature enhancement in ΔF508 CFTR rescue at 30°C. Interestingly, while the recovery of
both bands B and C at 30° C were initially improved by preincubation between 0.5 and 3 h at
40° C, the TI value was not strongly influenced by extending the duration of the mild heat
stress treatment beyond this time-point (Fig. 6A; Fig; 6B, lower panel, closed circles). These
results suggest that even short exposure to mild heat stress can augment the efficiency of ER
export of ΔF508 CFTR at reduced temperature in HEK-ΔF cells. While we have focused on
mild-heat stress (40° C), we have found that acute heat shock (42° C, 30 min) as well as
exposure to the HSF-1 activating drug celastrol (79,80) yields similar results (data not shown),
both largely stabilizing band B prior to appearance of I+C.
Low temperature enhances coupling of ΔF508 CFTR to the COPII machinery in response to
changes in cytoplasmic chaperone recruitment
To begin to explore the underlying basis for the temperature-dependent export of ΔF508, we
examined its interaction with the Hsp70, Hsp90 and the COPII cargo selection subunit Sec24
(16). For this purpose, HEK-ΔF or BHK-ΔF cells were transferred from 37° C to 30° C and
incubated for increasing time. CFTR-containing protein complexes were isolated by co-
immunoprecipitation and components of the CFTR-containing protein complexes were
analyzed by immunoblotting. Recovery was normalized to the level of band B in each
immunoprecipitate.
In HEK-ΔF cells, Hsp90 showed an initial association which dropped by 60 min of incubation
at 30° C (Fig. 7A; Fig. 7B, upper panel). In contrast, Hsp70 showed an increase in association
with ΔF508 following temperature shift (Fig. 7A; Fig. 7B, middle panel) that peaked by 0.5 h
and partially declined with increasing time of incubation (Fig. 7). Interaction with Sec24
following temperature shift showed a lag period (~1 h) followed by a significant increase at
the 3 h time-point, presumably reflecting formation of a transient but larger exportable pool of
CFTR (Fig. 7A; Fig. 7B, lower panel). Thus, temperature shift appears to result in a temporal
response to core inducible folding chaperones (13) that facilitates folding events leading to
stabilization and productive interaction with the COPII machinery in HEK-ΔF cells. In
contrast, in the BHK-ΔF cell line, which does not support the export of ΔF508 at reduced
temperature, we did not observe a significant change in the recruitment of Hsp70, Hsp90 or
Sec24 relative to the total band B presence in the immunoprecipitate over the time course of
the experiment (Fig. 7). These results underscore a potentially important role for Hsp70/Hsp90
client interactions along with other unknown factors found in HEK293 cells in the
conformational maturation of ΔF508 CFTR at reduced temperature for recognition by the
COPII machinery.
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What has not been clearly addressed is the role of chaperone systems in export of ΔF508 from
the ER following incubation at reduced temperature. If ΔF508 obtains a more native fold at
reduced temperature, then the efficiency of export should parallel that observed for wild-type
CFTR in the same cell line, albeit with reduced kinetics reflecting the decrease in temperature
that would presumably stabilize the fold thermodyamically. If on the other hand, reduced
temperature represents a unique folding state (either on or off pathway folding intermediates),
then only certain chaperone environments may be capable of supporting folding in a manner
that is acceptable for export. Indeed, that is what we found. We suggest the reduced temperature
fold requires processing with a unique balance of components that could differ, at least in part,
from the fold generated at physiological temperature. In general, this may be true for a number
of temperature-sensitive mutant phenotypes.
Our Recent biochemical and biophysical analysis of the export of the 15 kDa secreted protein
transthyretin (TTR) yielded insight into the importance of both kinetic and thermodynamic
features of protein folding pathways that contribute to export from the ER (20,37,67). Even
energetically destabilized variants were efficiently exported for the ER. These results suggested
that export is not necessarily a quality control driven pathway, a decision frequently thought
to reflect acquisition of an energetically stabilized native fold that prevents targeting to ERAD
(81). Rather, this more likely reflects the activity of folding metabolic pathways that is sensitive
to a minimum energetic threshold for coupling of cargo to COPII (38). Such pathways are
likely unique for each protein fold and are highly adaptable based on the composition of the
folding environment (37–39). It is now reasonable to consider the possibility that ΔF508 falls
outside an acceptable minimal export energetic threshold (38) at 37°C in most cell types
examined. Thus, a limitation in the kinetics of CFTR folding imposed by the Phe508 deletion
emphasizes the possibility that the difference between the export of wild-type and ΔF508 CFTR
largely reflects a difference in an energetically prohibitive intermediate folding step within this
metabolic pathway dictated by the capacity of the local chaperone biology, that is, the
proteostasis environment (20), to adequately support processing of CFTR through the folding
pathway (20,38,39,67). This may reflect the absence of 508 Phe in a critical hinge region
connecting the NBD1 region to cytoplasmic loop 4 (82), disrupting sequential folding kinetics.
The fact that export of ΔF508 and wild-type CFTR may require specialized chaperones found
in some mammalian cell lines (e.g. HEK293) but not others (e.g. our BHK-ΔF), helps us to
understand why the yeast Saccharomyces cerevisiae is unable to support the export of even
wild-type CFTR given its high evolutionary divergence-encompassing significant changes in
protein folding and trafficking metabolic pathways that have evolved to handle a different
spectrum of cargo folds and their associated energetics (55,57,83). Because yeast ERAD
pathways efficiently recognize CFTR and other proteins for degradation (65), we suggest that
the unfolded state harbors a more ‘ancient’ and conserved energetic feature that targets CFTR
efficiently to the degradative branch of these pathways. The requirement for a specialized
folding machinery is consistent with the highly variable rates of transport of wild-type CFTR
and processing of ΔF508 to band C at both reduced temperature and 37° C in different cell
lines ((47) and references therein). This poses a challenge to the CF field in clearly defining
the relevant folding and trafficking components responsible for human disease in the lung and
other CFTR-requiring tissue environments (13).
Several lines of evidence now favor the interpretation that the kinetic defect in ΔF508 that is
bypassed by incubation at reduced temperature reflects potential folding intermediates in the
maturation of NBD1 (16,68) and/or its inter-domain interactions (5,12,82,84). We have
observed that in the CFTR interactome, ΔF508 is potentially trapped in a chaperone-linked
folding intermediate(s) (13). Changing the level of activity of one of the Hsp90 co-chaperones
found in the folding interactome, Aha1, promoted stability and export of ΔF508 to the cell
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surface at physiological temperatures with the partial recovery of chloride channel activity
(13). These results are consistent with our interpretation that both the composition and balance
of chaperone components that constitute the chaperome environment in the cell can make an
important difference in ΔF508 function (13).
We have used the ratio of (I + C)/B as a trafficking index (TI) to reflect the overall balance of
competing pathways that maintain CFTR in a functional state at the cell surface at steady-state.
It provides a general measure for comparison of different folding (13), stability and trafficking
environments that collectively contribute to this state. While the ratio of ΔF508 and wild-type
TI’s in HEK293 cells incubated at 30°C was ~0.3 at steady-state, the ratio of ΔF508 to wild-
type TI’s in BHK cells was nearly an order of magnitude smaller (~0.03), emphasizing a
significant difference in the capacity of the two cell types to produce and maintain a potentially
functional pool of ΔF508 at the cell surface at reduced temperature. Thus, at 30° C, the match
between the energetics of the chemical fold and the capacity of the local biological folding
pathway(s) that can link ΔF508 to the export machinery may be critical for a partially folded
intermediate to achieve export and remain stable at the cell surface (37). Indeed, a number of
observations show that following export at reduced temperature, shift of cells to 37°C yields
a channel with altered function that is more rapidly targeted to lysosome than wild-type CFTR
(6,18,48,50). This could reflect the export of a distinct temperature-dependent, partially
destabilized folding intermediate that is not necessarily representative of what we need to
achieve in rescue of disease in the normal tissue environment.
We have found that in addition to cell-type specificity of ΔF508 CFTR export at reduced
temperature, heat stress protocols (either mild or acute) enhanced export in permissive cells
(e.g., HEK293) after temperature shift-more so than at physiologic temperature. We observed
that mild heat stress modified the overall balance of ERAD and export to favor export at reduced
temperature resulting in an improved TI. The effects of heat stress and stress-related pathways
on cellular metabolism are well-characterized and involve induction of expression of a large
number of cytosolic and ER luminal chaperones among many other components (75,85).
Moreover, we have found that small molecules such as celastrol (75) that stimulate the heat
shock pathway also stabiliize CFTR for reduced temperature export (data not shown) (86).
This finding is in agreement with previously projected roles of Hsp70 and Hsp90 pathways in
CFTR folding (4,13,24). While stress inducible factors could include specific Hsp70 and Hsp90
isoforms, they also likely include the many specialized components that regulate ER lumenal
or cytosolic chaperome or export pathways (13,56,57,61,63,87–89). Thus, it is apparent that a
newly synthesized pool of CFTR transferred to an energetically more permissive folding
condition (e.g., reduced temperature) can be more effectively targeted for export when given
an enhanced folding environment provided by stress-related responses.
To begin to gain insight into the mechanism of rescue, we observed that HEK-ΔΦ cells
incubated at reduced temperature showed transient changes in the association of ΔF508 CFTR
with the COPII component Sec24 (43) and that this change was preceded by changes in the
interaction of ΔF508 with Hsp70 and Hsp90 (13,59,60,62,87). Whereas Hsp70 association
increased upon shift to reduced temperature prior to restoration of its coupling to the COPII
machinery as scored by recognition of Sec24, we observed a gradual decrease in Hsp90
association raising the possibility that a folding intermediate involving these chaperone systems
may become resolved in response to the change in temperature, although the stoichiometry of
these interactions remains to be determined. Whether this indicates that Hsp70 must be
recruited to initiate new folding events occurring at reduced temperature, or that an improper,
more stable interaction of ΔF508 with the Hsp90 chaperone system at physiological
temperature precludes export from the ER (13) can be resolved at reduced temperature, or both,
remains to be determined.
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The ability of cell-specific and heat inducible factors to increase ΔF508 trafficking from the
ER at physiological temperatures raises the possibility that, in addition to small molecules
referred to as pharmacological chaperones (PCs) that may directly bind and stabilize the CFTR
fold, (90–98), another class, which we now refer to as proteostasis regulators (PRs) (20), could
be used to augment the folding properties of the cellular chaperome pool to promote rescue
(13). Intriguingly, effective PRs might be expected to improve the overall cellular folding/
stability environment for a particular mutant, perhaps independent of its cellular location. Thus,
unlike reduced temperature, PRs could, in principle, not only stabilize the fold for export at
physiological temperature, but in addition, provide a favorable environment for stability at the
cell surface leading to the observed increase in the TI. The fact that we observe clear differences
in the response of ΔF508 to reduced temperature in HEK293 and BHK cells, and to stress-
related responses, raises the possibility that different mammalian tissues harboring ΔF508 may
respond differentially to both PC and PR approaches (20,38). Our results are consistent with
the recent observation that mouse and pig ΔF508 are more efficiently processed to C band than
human ΔF508 in a primate, human or pig cell line (99). Thus, not only are the effects of the
Phe508 deletion on cell surface delivery dependent on the local folding and trafficking
environment (shown herein), but evolutionary divergent polypeptide chain sequences
contribute to the energetic profile that is sensitive to a particular folding environment. This is
not unlike the ability of different cis suppressor mutations to have differential effects on rescue
the human ΔF508 phenotype (18,19). Identification of the components that define the folding
network in different cell types that differentially facilitate ER export and stability of wild-type
and ΔF508 CFTR will be critical for our understanding of the balance between the energetics
of the chemical fold, and the role of biological factors and/or genetic modifiers in CF disease
that can influence these pathways (13,30).
Materials and Methods
Antibodies and chemicals
The following antibody reagents were used: a monoclonal antibody (M3A7) against an epitope
at the C-terminal end of the second nucleotide binding domain of human CFTR (100),
monoclonal antibodies 3C5 from B.M. Jockusch (University of Cologne, Cologne, Germany)
and 3A3 from Affinity BioReagents (Golden, CO) that recognizes both constitutive and
inducible forms of Hsp70, and an anti- Hsp90 polyclonal antibodies Hsp90 (H-114) from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). The antibodies for Hsp70 and Hsp90 recognize
both major isoforms of each protein. Anti-Sec24 polyclonal antibodies were raised against a
recombinant fusion protein between glutathione-S-transferase and human Sec24C. Protein G
Sepharose 4 Fast Flow was purchased from Amersham Biosciences Corp (Piscataway, NJ).
Celastrol was a kind gift provided by Dr. Richard I. Morimoto (Northwestern University,
Evanston, IL).
Cell lines
Baby hamster kidney (BHK) cells stably expressing wild-type or ΔF508 CFTR were obtained
from Dr. John Riordan, University of North Carolina (101), and were maintained in DMEM
supplemented with F12, 5% fetal bovine serum (FBS), 100 units/ml each of penicillin and
streptomycin, and 500 mM methotrexate (Xanodyne Pharmacal, Inc., Florence, KY). Human
embryonic kidney (HEK) 293 cells stably expressing wild-type or ΔF508 CFTR were provided
by Dr. Neil A. Bradbury (University of Pittsburgh School of Medicine, Pittsburgh, PA), and
maintained in DMEM, 10% FBS, 100 units/ml each of penicillin and streptomycin, and 150
mg/ml hygromycin B (CN Biosciences, Inc., La Jolla, CA).
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Cell lysis and CFTR quantification
Cells were washed twice with ice-cold phosphate-buffered saline (PBS), and lysed in 50 mM
Tris-HCl (pH 7.4), 150 mM NaCl, and 1% TX-100 (v/v), supplemented with complete protease
inhibitor cocktail tablets (Roche Diagnostics GmbH, Mannheim, Germany) for 30 min on ice.
The lysates were cleared by centrifugation at 16,000 × g for 20 min. The protein concentration
of the lysates was determined using the Coomassie Protein Assay Kit (Pierce Biotechnology,
Rockford, IL) and in most of the experiments equal protein amounts of lysates were loaded
and were separated by SDS-PAGE, immunoblotted with the indicated antibodies, and
visualized by ECL. The density of the bands in the linear exposure range was quantified on a
Personal Densitometer SI from Amersham Biosciences Corp. (Piscataway, NJ), using the
image processing program ImageJ (National Institutes of Health), or using an AlphaInnotech
Fluorochem SP (AlphaInnotech, San Leandro, CA).
Immunoprecipitation
Monoclonal antibody M3A7 was covalently coupled to Protein G Sepharose 4 Fast Flow beads
as described (102). Cells were washed twice with cold PBS and were lysed as described above.
The lysates were incubated with the M3A7-coated Protein G beads overnight at 4°C. The beads
were washed with lysis buffer. CFTR and its co-immunoprecipitating proteins were eluted with
50 mM Tris-HCl (pH 6.8) and 1% SDS. The proteins in the eluant were then separated by SDS-
PAGE, immunoblotted with specific antibodies and quantified as described above.
Pulse chase analysis of CFTR
Cells expressing wild-type CFTR were pulse labeled for 30 min with EasyTag L-35S-
Methionine (NEN, Boston, MA), and chased in the presence of excess cold Met for the
indicated periods of time in the Results. For ΔF508-expressing cells, pulse labeling was
extended to a total of 1 h to bring the signal to detectible level. CFTR was recovered by
immunoprecipitation essentially as described above. The radioactivity of CFTR bands were
visualized by autoradiography and quantified by using a PhosphoImager SI or a STORM
imaging system (Molecular Dynamics, Sunnyvale, CA).
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Fig. 1. Export of CFTR in BHK and HEK stable cell lines
(A) Transport of wild-type CFTR in BHK and HEK293 cells stably expressing the protein at
37° C were performed and analyzed using a pulse-chase protocol as described in the Materials
and Methods. The percent of CFTR in bands B or C relative to the total observed at time = 0
h was determined at the indicated time-points. Experiments were performed in duplicate, and
the means and the standard errors of the mean (SEMs) are shown. (B) BHK and HEK293 cells
stably expressing wild type or ΔF508 CFTR (BHK-ΔF and HEK-ΔF, respectively) were
incubated at 37° C. Cell lysates were separated by SDS-PAGE and immunoblotted with the
anti-CFTR monoclonal antibody M3A7. Given that the BHK cell lines express higher levels
of CFTR relative to the HEK293 cell lines, BHK lysates were generally loaded at 25%–30%
Wang et al. Page 19













total protein relative to that used for HEK293 lysates, with sodium butyrate induced BHK
lysates loaded at 10–15% of that of HEK293 lysates (see Fig. 2B below). Asterisk indicates
an ER form that results from translation from a downstream start codon (103).
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Fig. 2. HEK-ΔF but not BHK-ΔF supports the reduced temperature-dependent export of ΔF508
CFTR from the ER
(A) HEK cells stably expressing wild-type CFTR were pulsed at 37°C and chased for indicated
time at either 37° or 30° C as described in the Materials and Methods. CFTR was recovered
by immunoprecipitation, detected by autoradiography and quantified as described in the
Materials and Methods. The percent of total CFTR in band B or C relative to the total observed
at time = 0 h was determined at the indicated time-points. (B) HEK-ΔF cells were incubated
at the indicated temperature for 21 h. BHK-ΔF cells incubated in the absence or presence of
sodium butyrate (butyrate in figure) were similarly incubated at the indicated temperature for
21 h. Cells were lysed, equal protein amounts of cell lysate were loaded for each cell type (see
Fig. 1 legend) and separated by SDS-PAGE. CFTR was detected by immunoblotting and
quantified as described in the Materials and Methods. The (I+C)/B ratio denoted as trafficking
index (TI) for the distribution of CFTR at steady-state was determined as described in the text
of the Results.
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Fig. 3. Effect of reduced temperature on ΔF508 transport
(A) HEK-ΔF and BHK-ΔF cells were incubated at 30° C for indicated time. Cells were lysed
and equal protein amounts of lysates from each cell type were loaded and separated using SDS-
PAGE (see Fig. 1 legend). CFTR was detected by immunoblotting and quantified as described
in the Materials and Methods. (B–E) Quantitation of the levels of B, I or C are expressed as
percentage of band B observed at time = 0 h (B–D).
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Fig. 4. Mild heat stress promotes export of ΔF508 only in the HEK-ΔF cell line
HEK-ΔF (A–D) and BHK-ΔF (E–G) cell lines were incubated at 30° C for indicated time with
or without prior preincubation at 40° C for 21 h. Cells were lysed and equal protein amounts
of lysates were loaded (see Fig. 1 legend) and separated using SDS-PAGE. CFTR was detected
by immunoblotting and quantified as described in the Materials and Methods. Levels of band
B and bands I + C were normalized to the band B density observed at time = 0 h. In panel (D),
the TI is indicated by the open (preheat) and closed (no preheat) squares.
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Fig. 5. Pulse-chase analysis of the effects of mild heat stress (40°C) on the export of ΔF508 CFTR
at reduced temperature
(A) The HEK-ΔF cell line was pulsed at 37° C and chased at 30°C for indicated time with or
without prior preincubation at 40° C for 21 h. CFTR was recovered by immunoprecipitation
and quantified as described in Fig. 1 legend and the Materials and Methods. The two panels
were cropped from the same film derived from a single SDS-PAGE. (B–C) Indicated is the
percent of CFTR in band B or I + C relative to the total observed at time = 0 h in the no preheat
control. (D) The TI is indicated for each time point in panel A.
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Fig. 6. Differential effects of heat stress on ΔF508 folding and export in the HEK-ΔF cell line
(A) HEK-ΔF cells were incubated at 40°C for the indicated time before preparation of cell
lysates (time = 0 h), or incubated for an additional 18 h at 37° C or 30° C. Equal protein amounts
of cell lysates for each cell time were loaded and separated using SDS-PAGE. CFTR was
detected using immunoblotting (representative panel shown) as described in the Materials and
Methods. (B) The levels of band B (upper panel) and bands I+C (middle panel) are shown for
each condition. In the lower panel, the TI is shown. Experiments were conducted in duplicate
with the mean and SEM shown. (C) HEK-ΔF cells were incubated at 40° C for 3 h (preheat)
in the presence or absence of actinomycin D (Act D). Subsequently, the cells were incubated
at 30° C for 18 h in the absence of Act D. HEK-ΔF cells without preheat served as controls.
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Equal protein levels of cell lysates were loaded and separated by SDS-PAGE and the levels of
CFTR determined as described in the Materials and Methods (representative panel shown).
Experiments were conducted in triplicate with the mean and SEM shown in the lower panel.
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Fig. 7. The temperature-dependent export of ΔF508 CFTR in HEK293 cells involves changes in
chaperone recruitment followed by increased coupling to Sec24
(A) BHK-ΔF or HEK-ΔF cells were incubated at 30° C for the indicated periods of time and
CFTR was recovered by immunoprecipitation as described in the Materials and Methods. The
immunoprecipitate was separated using SDS-PAGE and analyzed by immunoblotting with the
indicated antibodies. HEK293 cells not expressing CFTR served as a negative control. (B) The
amount of Hsp90, Hsp70 and Sec24 present in the control (no CFTR) immunoprecipitates was
subtracted with the value in each of the corresponding immunoprecipitates, then normalized
to the level of CFTR band B recovered at each time point. The data is expressed as a fractional
value relative to the level observed at time = 0 h. In HEK-ΔF cells, experiments were conducted
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in triplicate, and asterisks indicate statistically significant difference between the specific time
point and the zero time point using the unpaired 2-tailed t-test analysis (* for p<0.05 and **
for p<0.01). The mean and SEM are shown for duplicate samples with BHK-ΔF cells.
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